Johnson & Johnson (NYSE:JNJ)

100.80
BATS BZX Real-Time Price
As of 11:20am ET
 -1.72 / -1.68%
Today’s Change
92.46
Today|||52-Week Range
109.49
-3.61%
Year-to-Date
Stock Market News for March 06, 2015 - Market News
10:55am / Zacks.com
Benzinga's M&A Chatter for Monday March 2, 2015
Mar 02 / Benzinga
Pfizer's Prevenar Cleared in the EU for New Indication - Analyst Blog
Mar 05 / Zacks.com
Cardinal Health Acquires Johnson & Johnson's Cordis in a $1.9 Billion Deal
Mar 02 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics
Mar 05 / FT.com
Is Fake Wood Flooring From China Killing You or Your Investments?
Mar 02 / TheStreet.com
AbbVie joins the pharma chain reaction
Mar 05 / FT.com
'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $...
Mar 02 / Benzinga
Vertex climbs on drug approval hopes
Mar 05 / FT.com
What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog
Mar 02 / Zacks.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher
Mar 05 / TheStreet.com
3 Stocks Moving The Drugs Industry Upward
Mar 02 / TheStreet.com
Centerview builds record on pharma deals
Mar 05 / FT.com
GSK-Novartis deal 'a model' for industry
Mar 02 / FT.com
Company News for March 05, 2015 - Corporate Summary
Mar 05 / Zacks.com
Stock Market News for March 02, 2015 - Market News
Mar 02 / Zacks.com
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Mar 05 / MotleyFool.com
UPDATE: Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cor...
Mar 02 / Benzinga
Frontrunning: March 5
Mar 05 / Investing Channel
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
Mar 01 / MotleyFool.com
Abbvie/Pharmacyclics: pay to play
Mar 05 / FT.com
3 Stocks That Could Lose You a Lot of Money
Feb 27 / MotleyFool.com
Why Pharmacyclics Inc. Stock Burst Higher
Mar 05 / MotleyFool.com
Cramer: Pharmacyclics-Johnson & Johnson Deal Unlikely at This Price
Feb 27 / TheStreet.com
Q&A - why Abbvie had to strike $21bn Pharmacyclics deal
Mar 05 / FT.com
3 Dividend Aristocrats We Want to Own
Feb 27 / MotleyFool.com
Benzinga's M&A Chatter for Wednesday March 4, 2015
Mar 04 / Benzinga
The Best All-Around Stock in the Market
Feb 27 / MotleyFool.com
Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson
Mar 04 / Benzinga
The single best stock to own today
Feb 26 / CNNMoney.com
Fast Money Halftime Report Final Trade From March 4
Mar 04 / Benzinga
Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog
Feb 26 / Zacks.com
AbbVie trumps J&J in deal for cancer drugmaker
Mar 04 / FT.com
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
Apple Inc., Microsoft Corporation, Google Inc: Are We Witnessing A New Tech Bubble?
Mar 04 / Investing Channel
Why Pharmacyclics, Inc. Soared Higher Today
Feb 25 / MotleyFool.com
Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
Mar 04 / Zacks.com
Hospira and Celltrion launch biosimilars
Feb 24 / FT.com
These ads ran before ISIS videos
Mar 03 / CNNMoney.com
Why Depomed Inc. Sky-Rocketed Today
Feb 24 / MotleyFool.com
Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog
Mar 03 / Zacks.com
Apple eyes trillion-dollar market cap
Feb 24 / FT.com
Halozyme Q4 Loss Narrower-than-Expected, Revenues Up - Analyst Blog
Mar 03 / Zacks.com
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
Feb 22 / MotleyFool.com
Stock Market News for March 03, 2015 - Market News
Mar 03 / Zacks.com
Why Microsoft's Massive Debt Sale Is a Savvy Move
Feb 22 / MotleyFool.com
Guess Which Company Just Toppled Amazon.com Inc's Top Spot For Business Reputation
Mar 03 / MotleyFool.com
The $10 Billion Reason That This Tiny Biotech Stock Could Soar
Feb 22 / MotleyFool.com
Is Xoma Corporation A Buy?
Mar 03 / MotleyFool.com
3 Proven Ways to Get More Income in Retirement
Feb 21 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account